Plena Global Holdings Enters into Supply Agreement with Relevium

Plena Global Holdings Enters into Supply Agreement with Relevium

Plena Global Holdings is pleased to announce that it has entered into a supply agreement with Relevium Technologies. Beginning in January 2019, Plena will supply full spectrum CBD oil to Relevium's supply chain partners in Europe from our medical cannabis grow production assets based in legalized countries in South America.

Relevium intends to introduce world class Cannabinoid based nutraceutical supplements into the European market using high quality GMP grade medical cannabis products. With a focus on the growing health and wellness sector, Relevium is a TSX-Listed company and through its wholly-owned subsidiary, Biocannabix Health Corporation, is incorporating cannabinoids into its nutraceutical strategy to provide its European retail customers access to the health benefits of cannabis through its unique formulations and established brands. 

Aurelio Useche, Relevium CEO stated: "Our supply partnership with Plena Global Holdings is a critical milestone for Relevium as it ensures a steady long-term supply of superior quality full spectrum CBD oil for the company's nutraceutical retail brands currently being launched in Europe".

Plena Global Holdings currently operates 130 million square feet of committed grow operations that meet Canadian and European standards making the company the ideal partner for supplying CBD oil Further to that, Plena’s management team brings together some of the world's top cannabis scientists, growers, extraction specialists, and medical leaders, to develop and deliver the highest quality medical marijuana supplies to the world.


Read more here.

Plena is deeply rooted in its commitment to educating people on the real benefits of medical cannabis and meeting the needs of a flourishing market with cGMP grade products